Since the 'three-child' relaxation and the government's call to 'improve fertility-support policy… reduce family burdens,' multiple support policies raise new requirements for insurance work. Beijing, Guangxi, Inner Mongolia, and Gansu have included ART in insurance. In Guangxi (from 2023-11-01), 12 therapeutic ART items are covered; the fund paid ~114 million yuan at 59.13%, benefiting ~55,800 people—showing the effort to ease burdens. After coverage, ART outpatient volume in the autonomous region reached 607,700 visits, up 35.64% year-on-year.

Before coverage, a full IVF cycle cost about 30,000–50,000 yuan; for families needing multiple attempts, tens of thousands more. Take Ms. Zhang using ICSI (second generation): pre-coverage, retrieval (2,400) + injection (3,346) + culture (4,200) + transfer (2,300) = 12,246. Post-coverage, as an employee-insurance member at 70%, she pays 720/1,003.8/1,260/690 = 3,673.8, reimbursed 8,572.2; as a resident member at 50%, she pays 1,200/1,673/2,100/1,150 = 6,123, reimbursed 6,123. Actual reimbursement depends on treatment.

Per Yicai, Beijing's single-cycle IVF cost is about 30,000–50,000; at the median, insurance covers about 23% of the cycle, ~8,000–11,000. Including ART in national insurance is an important step in China's healthcare system, benefiting patients and advancing the field. Scope and rates vary by region/hospital, but insurance eases the economic burden. (More info: QR code or 181-0136-5219.)